{'fraction_non_alphanumeric': 0.014821272885789015, 'fraction_numerical': 0.0, 'mean_word_length': 5.833333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Brain-Computer Interface Based on Magnetic Particle Imaging For Diagnostic and Neurological Rehabilitation in Multiple Sclerosis

Applications of brain-computer interface (BCI) based on data of magnetic particle image (MPI) scanning of biological effector bound in-vivo magnetic nanoparticles (MNs) can be a desirable method of providing noninvasive diagnostic and neurological rehabilitative solutions for patients having various neurological dysfunctions such as, Multiple Sclerosis (MS). MNs may be dispensed to a patient for noninvasive localized monitoring of neurodegenerative disease by measuring changes in action potential along a neuron or by measuring levels of inflammation by determining concentrations of cellular debris at a particular point of interest in the brain such as at impaired nerve fibers of a neuron. The MNs may be configured for bidirectional communication with an electronic device in electrical communication with a MPI machine. Further, these MNs may be configured for drug delivery to a predetermined location associated with brain inflammation or to actuate the pharmacokinetic expulsion of toxic cellular debris.